The following is a summary from our lobbying firm Cornerstone Government Affairs of the two small business loan programs created as a result of the COVID-19 Pandemic. The first program was created through the passage of what we are calling the “COVID-I” legislation. That bill created a $1 billion fund to immediately assist small businesses…

Today Georgia Bio joins several other associations to sign-on the U.S. Chamber Letter to Secretary Mnuchin, Secretary Ross, Ambassador Lighthizer, and Director Kudlow. The letter respectfully ask that the Trump administration defer moves to expand the reach of “Buy American” mandates to the medical equipment and biopharmaceutical sector during the present national emergency. Please see…

Legislation Supplemental III – “COVID-III” The hope continues to be that a deal can come together, that a time agreement can be reached, and that the Senate can vote expeditiously – if not yesterday night, then certainly by today. Absent any deal, the Senate would vote on cloture on the motion to proceed to the…

On behalf of Georgia Bio and our members we asked Governor Kemp to consider shelter in place orders to prevent the spread of COVID-19 in Georgia to allow biopharmaceutical and medical device and diagnostics companies and distributors to operate so that prescription drugs and medical supplies remain accessible to those who need them. To effectuate…